Trailing-twelve-month (TTM) revenue is $17.63 Billion with a year-over-year growth of +3.41%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-10-03 | $4,469,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2026-01-02 | $4,207,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-17 |
| Q1 FY2026Period ended 2026-04-03 | $4,400,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-05 |
| Q2 FY2026Period ended 2026-07-03 | $4,558,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $17,634,000,000 |
Current P/S: $16,708,021,550 market capitalization ÷ $17,634,000,000 TTM revenue = 0.95x.
Market capitalization source: FMP quote. Quote observed 2026-09-14T20:00:03.000Z. Latest revenue period ended 2026-07-03.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-07-03): $4.56B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-14T21:15:55.878Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-01-02 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-01-02 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202021-01-01 · USD | FY20212021-12-31 · USD | FY20222022-12-30 · USD | FY20232023-12-29 · USD | FY20242025-01-03 · USD | FY20252026-01-02 · USD |
|---|---|---|---|---|---|---|
| Civil Segment | $3.0B | $3.2B | $3.5B | $3.7B | $5.0B | $5.1B |
| Defense Solution Segment | $7.3B | $8.0B | $8.2B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202021-01-01 · USD | FY20212021-12-31 · USD | FY20222022-12-30 · USD | FY20232023-12-29 · USD | FY20242025-01-03 · USD | FY20252026-01-02 · USD |
|---|---|---|---|---|---|---|
| Non-US | $1.0B | $1.1B | $1.2B | $1.3B | $1.4B | $1.4B |
| UNITED STATES | $11.2B | $12.5B | $13.1B | $14.0B |
$17.63B
$17.63 Billion
+3.41%
vs. $17.05B a year ago (TTM)
+5.87%
5 Year compound annual growth rate
1 Year
+3.41%
3 Year
+5.90%
5 Year
+5.87%
10 Year
+13.02%
15 Year
+3.08%
20 Year
+4.45%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $17.17B | +$512.00M | +3.07% |
| 2024 | $16.66B | +$1.22B | +7.93% |
| 2023 | $15.44B | +$1.04B | +7.24% |
| 2022 | $14.40B | +$659.00M | +4.80% |
| 2021 | $13.74B | +$1.44B | +11.71% |
| 2020 |
TTM Growth
+3.41%
3-Year CAGR
+5.90%
5-Year CAGR
+5.87%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-14T21:15:55.878Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $2.0B |
| $2.2B |
| Health Segment | $2.0B | $2.5B | $2.7B | $3.0B | N/A | N/A |
|---|
| National Security Solutions | N/A | N/A | N/A | N/A | $9.6B | $9.9B |
|---|
| N/A |
| $12.30B |
| +$1.20B |
| +10.84% |
| 2019 | $11.09B | +$900.00M | +8.83% |
| 2018 | $10.19B | +$24.00M | +0.24% |
| 2017 | $10.17B | +$3.13B | +44.40% |
| 2016 | $7.04B | +$1.96B | +38.48% |
